Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,889-3,900 of 4,306
Other study type icon
CompletedNCT00824031

Mental Care in Spain

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ferrol
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Spain
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
WithdrawnNCT02286206

the Effect of Dosing on Clozapine Levels

This summary needs review. Please check the official study record and contact the research team for details.

In Vancouver
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03225027

Study on Communication Comprehension in the Schizophrenic Spectrum

This summary needs review. Please check the official study record and contact the research team for details.

In Cergy-Pontoise
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
Hôpital NOVO
Condition
Schizophrenia
Drug study icon
CompletedNCT01511510

Safety study of Repeated Doses of PF-04958242 in Schizophrenia

This study is completed in the United States. It is testing Repeated Doses of PF-04958242 for Schizophrenia.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Drug study icon
CompletedNCT02228395

Safety study of Single Doses Of PF-04958242 in Schizophrenia

This study is completed in the United States. It is testing Single Doses Of PF-04958242 for Schizophrenia.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Other study type icon
CompletedNCT00857064

Subjective Well Being of Schizophrenic Patients in Greece

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Agrinio
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 65 Years
Countries
Greece
Sponsor
AstraZeneca
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.